Tasly Pharmaceutical Group Co Ltd (600535) — Free Cash Flow Generation Index
Tasly Pharmaceutical Group Co Ltd (600535) has a Free Cash Flow Generation Index of 0.79x as of December 2025. Free cash flow of CN¥434.36 Million represents 1% of operating cash flow (CN¥552.13 Million). Read 600535 current and long-term liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Tasly Pharmaceutical Group Co Ltd Free Cash Flow Generation Index (2001–2025)
Historical FCF Generation Index trend for Tasly Pharmaceutical Group Co Ltd across 24 annual periods. Explore 600535 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Tasly Pharmaceutical Group Co Ltd (2001–2025)
Year-by-year Free Cash Flow Generation Index for Tasly Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see Tasly Pharmaceutical Group Co Ltd market cap and net worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.73x | CN¥1.04 Billion | CN¥1.42 Billion | CN¥381.26 Million | ▲ +1.8% |
| 2024 | 0.72x | CN¥1.45 Billion | CN¥2.01 Billion | CN¥564.94 Million | ▼ -2.8% |
| 2023 | 0.74x | CN¥1.91 Billion | CN¥2.58 Billion | CN¥668.82 Million | ▼ -10.1% |
| 2022 | 0.82x | CN¥1.88 Billion | CN¥2.29 Billion | CN¥403.45 Million | ▲ +3.5% |
| 2021 | 0.80x | CN¥2.23 Billion | CN¥2.80 Billion | CN¥571.73 Million | ▲ +3.1% |
| 2020 | 0.77x | CN¥1.38 Billion | CN¥1.79 Billion | CN¥408.81 Million | ▲ +36.6% |
| 2019 | 0.57x | CN¥949.37 Million | CN¥1.68 Billion | CN¥730.78 Million | ▲ +18.3% |
| 2018 | 0.48x | CN¥713.69 Million | CN¥1.49 Billion | CN¥780.10 Million | ▼ -12.4% |
| 2016 | 0.55x | CN¥629.05 Million | CN¥1.15 Billion | CN¥524.68 Million | ▲ +146.6% |
| 2015 | -1.17x | CN¥-397.84 Million | CN¥340.00 Million | CN¥737.84 Million | ▼ -422.3% |
| 2014 | -0.22x | CN¥-138.17 Million | CN¥616.76 Million | CN¥754.93 Million | ▲ +75.6% |
| 2013 | -0.92x | CN¥-317.39 Million | CN¥346.17 Million | CN¥663.56 Million | ▼ -1727.2% |
| 2012 | 0.06x | CN¥23.29 Million | CN¥413.31 Million | CN¥390.02 Million | ▲ +102.6% |
| 2011 | -2.13x | CN¥-287.44 Million | CN¥135.14 Million | CN¥422.58 Million | ▼ -467.1% |
| 2010 | 0.58x | CN¥228.92 Million | CN¥395.05 Million | CN¥166.13 Million | ▼ -18.2% |
| 2009 | 0.71x | CN¥283.58 Million | CN¥400.39 Million | CN¥116.80 Million | ▲ +26.5% |
| 2008 | 0.56x | CN¥145.69 Million | CN¥260.21 Million | CN¥114.51 Million | ▲ +510.3% |
| 2007 | 0.09x | CN¥20.33 Million | CN¥221.55 Million | CN¥201.23 Million | ▲ +111.2% |
| 2006 | -0.82x | CN¥-114.84 Million | CN¥140.56 Million | CN¥255.41 Million | ▼ -115.6% |
| 2005 | -0.38x | CN¥-81.43 Million | CN¥214.90 Million | CN¥296.33 Million | ▲ +53.7% |
| 2004 | -0.82x | CN¥-166.35 Million | CN¥203.27 Million | CN¥369.62 Million | ▲ +82.1% |
| 2003 | -4.57x | CN¥-269.74 Million | CN¥59.00 Million | CN¥328.74 Million | ▼ -1276.5% |
| 2002 | 0.39x | CN¥80.13 Million | CN¥206.22 Million | CN¥126.09 Million | ▲ +191.5% |
| 2001 | -0.42x | CN¥-35.59 Million | CN¥83.77 Million | CN¥119.35 Million | — |